CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,308 | -94.9% | 4,299 | -93.8% | 0.00% | -100.0% |
| Q2 2023 | $2,335,979 | +4.8% | 68,847 | +11.1% | 0.01% | -20.0% |
| Q1 2023 | $2,228,781 | +48.5% | 61,945 | +84.0% | 0.01% | +25.0% |
| Q4 2022 | $1,500,850 | +614.7% | 33,674 | +350.4% | 0.01% | +700.0% |
| Q3 2022 | $210,000 | -84.3% | 7,476 | -88.5% | 0.00% | -95.2% |
| Q1 2021 | $1,337,000 | -55.4% | 64,913 | -62.1% | 0.02% | -51.2% |
| Q4 2020 | $3,001,000 | +175.1% | 171,318 | +132.8% | 0.04% | +168.8% |
| Q3 2020 | $1,091,000 | +131.1% | 73,584 | +102.5% | 0.02% | +128.6% |
| Q2 2020 | $472,000 | – | 36,334 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |